A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Washington University School of Medicine
University of Southern California
National Institutes of Health Clinical Center (CC)
Bruckner Oncology
University of Florida
Albert Einstein College of Medicine
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Mayo Clinic
UroGen Pharma Ltd.
M.D. Anderson Cancer Center
Radiation Therapy Oncology Group
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
UroGen Pharma Ltd.
Japan Clinical Oncology Group
IRCCS San Raffaele
Centro Nacional de Investigaciones Oncologicas CARLOS III
Rutgers, The State University of New Jersey
SWOG Cancer Research Network
European Organisation for Research and Treatment of Cancer - EORTC
Mayo Clinic
Eli Lilly and Company